Back to search

Boston University

A self-assembling coiled-coil peptide platform for antibody-targeted therapeutics

Abstract

dc:description.abstract

Antibody-drug conjugates (ADCs) have revolutionized cancer treatment, yet significant challenges limit their therapeutic potential and hamper their advancement to first-line treatments. Traditional conjugation methods lack stability, site-specificity and spatial control, resulting in heterogeneous products with compromised pharmacokinetics, efficacy, and safety profiles. This thesis presents a platform for advancing ADC technology through developing a novel peptide-based conjugation strategy and expands it to diverse payloads to create safe next-generation therapeutics. We first developed a supramolecular assembly conjugation method based on coiled-coil peptides to generate a robust site-specific ADC. This approach affords modular conjugation of multiple payloads. An ADC created via this platform demonstrated efficacy in human ovarian cancer xenograft model. Next, we developed a gram-scale synthetic scheme of a multifunctional cathepsin B-responsive linker that facilitates controlled drug release from antibodies. This scheme is high-yielding and avoids chromatographic purification, providing a pure product at the gram scale. Building on the coiled-coil conjugation platform, we demonstrated its modularity by expanding beyond traditional cytotoxic payloads to create antibody-enzyme conjugates that leverage enzymatic activity for metastasis reduction. By conjugating DNase to a neutrophil targeting antibody, we ensured enzyme delivery to close proximity of neutrophil extracellular traps, thereby reducing lung metastatic burden in an orthotopic 4T1 metastatic breast cancer model. Finally, we introduced a "smart" ADC platform integrating tumor-targeting with novel Regulated Induced Proximity Targeting Chimeras (RIPTACs). This approach overcomes off-target toxicities by requiring both extracellular target recognition and intracellular target recognition, establishing safer, more selective antibody-based therapeutics. Collectively, this work provides a uniform toolbox for ADC engineering and introduces new concepts for designing next-generation antibody conjugates with alternative payloads and mechanisms of action.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Chemistry
Grantor
Boston University
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Ringaci, Alina
Advisor dc:contributor.advisor
  • Grinstaff, Mark W
ORCID dc:identifier.orcid

Subjects

dc:subject × 5

Rights

dc:rights
Statement dc:rights
  • Attribution 4.0 International
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/53607

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Ringaci, Alina. A self-assembling coiled-coil peptide platform for antibody-targeted therapeutics. doctoral thesis, Boston University, 2026. https://hdl.handle.net/2144/53607